Literature DB >> 6814621

Postmenopausal osteoporosis.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6814621      PMCID： PMC1500609     

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  6 in total

1.  Endometrial cancer and estrogen use. Report of a large case-control study.

Authors:  C M Antunes; P D Strolley; N B Rosenshein; J L Davies; J A Tonascia; C Brown; L Burnett; A Rutledge; M Pokempner; R Garcia
Journal:  N Engl J Med       Date:  1979-01-04       Impact factor: 91.245

2.  Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis.

Authors:  B L Riggs; J Jowsey; R S Goldsmith; P J Kelly; D L Hoffman; C D Arnaud
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

3.  Oestrogen and endometrial cancer: a reappraisal.

Authors:  J Collins
Journal:  J R Soc Med       Date:  1981-06       Impact factor: 5.344

4.  Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study.

Authors:  T A Hutchinson; S M Polansky; A R Feinstein
Journal:  Lancet       Date:  1979-10-06       Impact factor: 79.321

5.  Menopausal estrogen therapy and hip fractures.

Authors:  A Paganini-Hill; R K Ross; V R Gerkins; B E Henderson; M Arthur; T M Mack
Journal:  Ann Intern Med       Date:  1981-07       Impact factor: 25.391

6.  Bone response to termination of oestrogen treatment.

Authors:  R Lindsay; D M Hart; A MacLean; A C Clark; A Kraszewski; J Garwood
Journal:  Lancet       Date:  1978-06-24       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.